Candida albicans prosthetic hip infection in elderly patients: Is fluconazole monotherapy an option?

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 1, 2010, Pages 12-21

  Kelesidis, Theodoros ^a   Tsiodras, Sotirios ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTAZIDIME; CLINDAMYCIN; FLUCONAZOLE; IMIPENEM; ITRACONAZOLE; KETOCONAZOLE; NORFLOXACIN; VANCOMYCIN; ANTIFUNGAL AGENT;

AGED; ARTHROPLASTY; CANDIDA ALBICANS; CLINICAL FEATURE; COXITIS; HIP PAIN; HUMAN; INFECTIOUS ARTHRITIS; MONOTHERAPY; OSTEOARTHRITIS; PATHOGENESIS; PROSTHESIS INFECTION; RADIOGRAPHY; REVIEW; RHEUMATOID ARTHRITIS; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; CANDIDIASIS; CASE REPORT; FEMALE; HIP PROSTHESIS; INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; FLUCONAZOLE; HIP PROSTHESIS; HUMANS; PROSTHESIS-RELATED INFECTIONS; TREATMENT OUTCOME;

EID: 77149145530     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903253510     Document Type: Review

References (52)

1. Phelan DM, Osmon DR, Keating MR, Hanssen AD. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis 2002;34:930-938
2. Merrer J, D upont B, N ieszkowska A, D e Jonghe B, O utin H. Candida albicans prosthetic arthritis treated with fluconazole alone. J Infect 2001;42:208-209
3. Cushing RD, Fulgenzi WR. Synovial fluid levels of fluconazole in a patient with Candida parapsilosis prosthetic joint infection who had an excellent clinical response. J Arthroplasty 1997;12:950.
4. Fukasawa N, S hirakura K. C andida arthritis after total knee arthroplasty-a case of successful treatment without prosthesis removal. Acta Orthop Scand 1997;68:306-307
5. Simonian PT, Brause BD, Wickiewicz TL. Candida infection after total knee arthroplasty. Management without resection or amphotericin B. J Arthroplasty 1997;12:825-829
6. Darouiche RO, H amill RJ, Musher DM, Young EJ, H arris RL. Periprosthetic candidal infections following arthroplasty. Rev Infect Dis 1989;11:89-96.
7. Kohli R, H adley S. F ungal arthritis and osteomyelitis. Infect Dis Clin North Am 2005;19:831-851
8. MacGregor RR, S chimmer BM, S teinberg ME. R esults of combined amphotericin B-5-fluorcytosine therapy for prosthetic knee joint infected with Candida parapsilosis. J Rheumatol 1979;6:451-455
9. Goodman JS, S eibert DG, Reahl GE J r, Geckler RW. Fungal infection of prosthetic joints: a report of two cases. J Rheumatol 1983;10:494-495
10. Lichtman EA. C andida infection of a prosthetic shoulder joint. Skeletal Radiol 1983;10:176-177
11. Younkin S, E varts CM, S teigbigel RT. Candida parapsilosis infection of a total hip-joint replacement: successful reimplantation after treatment with amphotericin B and 5-fluorocytosine. A case report. J Bone Joint Surg Am 1984; 66:142-143
12. Lim EV, S tern PJ. C andida infection after implant arthroplasty. A case report. J Bone Joint Surg Am 1986;68:143-145
13. Koch AE. C andida albicans infection of a prosthetic knee replacement: a report and review of the literature. J Rheumatol 1988;15:362-365
14. Lambertus M, Thordarson D, G oetz MB. Fungal prosthetic arthritis: presentation of two cases and review of the literature. Rev Infect Dis 1988;10:1038-1043
15. Levine M, R ehm SJ, W ilde AH. I nfection with Candida albicans of a total knee arthroplasty. Case report and review of the literature. Clin Orthop Relat Res 1988;235-239
16. Iskander MK, Khan MA. C andida albicans infection of a prosthetic knee replacement. J Rheumatol 1988;15:1594-1595
17. Evans RP, N elson CL. Staged reimplantation of a total hip prosthesis after infection with Candida albicans. A report of two cases. J Bone Joint Surg Am 1990;72:1551-1553
18. Paul J, W hite SH, Nicholls KM, Crook DW. P rosthetic joint infection due to Candida parapsilosis in the UK: case report and literature review. Eur J Clin Microbiol Infect Dis 1992;11:847-849
19. Tunkel AR, T homas CY, W ispelwey B. Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. Am J Med 1993;94:100-103
20. White A, Goetz MB. Candida parapsilosis prosthetic joint infection unresponsive to treatment with fluconazole. Clin Infect Dis 1995;20:1068-1069
21. Cardinal E, B raunstein EM, Capello WN, Heck DA. C andida albicans infection of prosthetic joints. Orthopedics 1996;19: 247-251 (Pubitemid 26089388)
22. Hennessy MJ. I nfection of a total knee arthroplasty by Candida parapsilosis. A case report of successful treatment by joint reimplantation with a literature review. Am J Knee Surg 1996;9:133-136
23. Nayeri F, C ameron R, Chryssanthou E, J ohansson L, Soderstrom C. Candida glabrata prosthesis infection following pyelonephritis and septicaemia. Scand J Infect Dis 1997;29: 635-638
24. Dunkley AB, L eslie IJ. C andida infection of a silicone metacarpophalangeal arthroplasty. J Hand Surg (Br) 1997;22: 423-424
25. Wada M, Baba H, I mura S. Prosthetic knee Candida parapsilosis infection. J Arthroplasty 1998;13:479-482
26. Brooks DH, Pupparo F. S uccessful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J Arthroplasty 1998;13:707-712
27. Badrul B, R uslan G. Candida albicans infection of a prosthetic knee replacement: a case report. Med J Malaysia 2000; 55(Suppl C ):93-96
28. Yang SH, P ao JL, H ang YS. Staged reimplantation of total knee arthroplasty after Candida infection. J Arthroplasty 2001;16:529-532
29. Ramamohan N, Z eineh N, Grigoris P, Butcher I. C andida glabrata infection after total hip arthroplasty. J Infect 2001; 42:74-76 (Pubitemid 32631806)
30. Acikgoz ZC, S ayli U, Avci S, D ogruel H, G amberzade S. A n extremely uncommon infection: Candida glabrata arthritis after total knee arthroplasty. Scand J Infect Dis 2002;34: 394-396
31. Lerch K, K alteis T, Schubert T, Lehn N, Grifka J. P rosthetic joint infections with osteomyelitis due to Candida albicans. Mycoses 2003;46:462-466
32. Lazzarini L, M anfrin V, De Lalla F. Candidal prosthetic hip infection in a patient with previous candidal septic arthritis. J Arthroplasty 2004;19:248-252
33. Lejko-Zupanc T, M ozina E, V revc F. Caspofungin as treatment for Candida glabrata hip infection. Int J Antimicrob Agents 2005;25:273-274
34. Dumaine V, Eyrolle L, Baixench MT, Paugam A, L arousserie F, Padoin C, et al. Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine. Int J Antimicrob Agents 2008;31:398-399
35. Bland CM, T homas S. M icafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans. Ann Pharmacother 2009;43:528-531
36. Cuende E, B arbadillo C, M azzucchelli R, I sasi C, Trujillo A, Andreu JL. Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum 1993;22:224-241
37. Legout L, A ssal M, R ohner P, L ew D, B ernard L, H offmeyer P. Successful treatment of Candida parapsilosis (fluconazoleresistant) osteomyelitis with caspofungin in an HIV patient. Scand J Infect Dis 2006;38:728-730
38. Rex JH, W alsh TJ, S obel JD, Filler SG, Pappas PG, Dismukes WE, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:662-678
39. Adam B, B aillie GS, Douglas LJ. M ixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 2002;51:344-349
40. Silveira LH, C uellar ML, C itera G, C abrera GE, S copelitis E, Espinoza LR. Candida arthritis. Rheum Dis Clin North Am 1993;19:427-437
41. Brammer KW, F arrow PR, Faulkner JK. P harmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 1990;12(Suppl 3 ):S318-26.
42. Cappelletty D, E iselstein-McKitrick K. T he echinocandins. Pharmacotherapy 2007;27:369-388
43. Ernst EJ, K lepser ME, P faller MA. Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrob Agents Chemother 2000;44:1108-1111
44. Fohrer C, F ornecker L, N ivoix Y, Cornila C, M arinescu C, Herbrecht R. Antifungal combination treatment: a future perspective. Int J Antimicrob Agents 2006;27(Suppl 1 ):25-30.
45. Karlowsky JA, H oban DJ, Z hanel GG, G oldstein BP. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species. Int J Antimicrob Agents 2006;27:174-177
46. Perry M. Erythrocyte sedimentation rate and C reactive protein in the assessment of suspected bone infection-are they reliable indices? J R Coll Surg Edinb 1996;41:116-118 (Pubitemid 26107275)
47. Pagnano MW, T rousdale RT, Hanssen AD. O utcome after reinfection following reimplantation hip arthroplasty. Clin Orthop Relat Res 1997;192-204.
48. Lieberman JR, C allaway GH, S alvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res 1994;205-212
49. McDonald DJ, F itzgerald RH J r, I lstrup DM. T wo-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am 1989;71:828-834
50. Sia IG, B erbari EF, K archmer AW. P rosthetic joint infections. Infect Dis Clin North Am 2005;19:885-914.
51. Martinez LR, C asadevall A. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infect Immun 2006;74:6118-6123
52. Penk A, P ittrow L. R ole of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implants. Mycoses 1999;42(Suppl 2 ):91-96